3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
29
Recurrence
7
Neoplasms, Plasma Cell
2
Bone Marrow Neoplasms
1
Interventions
carfilzomib
1
Low-Level Light Therapy
1
Lenalidomide
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Bone Marrow Neoplasms
×
carfilzomib
×
Clear all
NCT03859427
2024-08-13
ARROW2
Amgen
Phase 3
Completed
454 enrolled
24 charts